David Seiffge

David Seiffge is a vascular neurologist, professor of clinical neurology at the University of Bern and head of the stroke unit at the Inselspital University Hospital in Bern, Switzerland. His major research interest is in anticoagulation, atrial fibrillation and intracerebral haemorrhage. He is the principal investigator of DO-IT (IV thrombolysis in patients on DOACs), ELAPSE (left atrial appendiage occlusion + DOAC in patients with breakthrough strokes) and MAX-ICH (a new care bundle for ICH therapy).